Found: 12
Select item for more details and to access through your institution.
Safety, immunogenicity and efficacy of the self-amplifying mRNA ARCT-154 COVID-19 vaccine: pooled phase 1, 2, 3a and 3b randomized, controlled trials.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47905-1
- By:
- Publication type:
- Article
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00590-x
- By:
- Publication type:
- Article
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00590-x
- By:
- Publication type:
- Article
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00573-y
- By:
- Publication type:
- Article
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.
- Published in:
- Journal of Neurology, 2020, v. 267, n. 4, p. 1070, doi. 10.1007/s00415-019-09671-9
- By:
- Publication type:
- Article
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials.
- Published in:
- 2019
- By:
- Publication type:
- journal article
N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels.
- Published in:
- European Heart Journal, 2019, v. 40, n. 33, p. 2785, doi. 10.1093/eurheartj/ehz209
- By:
- Publication type:
- Article
Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 314, p. 1, doi. 10.1126/scitranslmed.aac5272
- By:
- Publication type:
- Article
Results of a proof of concept, double-blind, randomized trial of a second generation antisense oligonucleotide targeting high-sensitivity C-reactive protein (hs-CRP) in rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0578-5
- By:
- Publication type:
- Article
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 4, p. 466, doi. 10.1111/bjh.13061
- By:
- Publication type:
- Article
Use of Dietary Yeast Saccharomyces cerevisiae Nitrogen by Lake Trout.
- Published in:
- Journal of the World Aquaculture Society, 1990, v. 21, n. 3, p. 205, doi. 10.1111/j.1749-7345.1990.tb01024.x
- By:
- Publication type:
- Article